Market Currents
Biotech firm Amgen (AMGN) expects to repurchase almost $5B worth of stock - or around 83.3M...
-
Thursday, December 8, 2011, 12:49 PM ETBiotech firm Amgen (AMGN) expects to repurchase almost $5B worth of stock - or around 83.3M shares at $60 a pop - following a Dutch auction. The buyback represents about half of a $10B program. Shares +0.4%. (PR)
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
